NEOPHARM INC
S-3MEF, EX-23.1, 2000-09-26
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: NEOPHARM INC, S-3MEF, EX-5.1, 2000-09-26
Next: NEOPHARM INC, 424B4, 2000-09-26



<PAGE>

                                                                  Exhibit 23.1

CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


As independent public accountants, we hereby consent to the incorporation by
reference in this registration statement of our report dated March 13, 2000
and to all references to our Firm included in this registration statement.


Arthur Andersen LLP

Chicago, Illinois
September 25, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission